AI assistant
Sending…
INSMED Inc — Director's Dealing 2022
Jan 7, 2022
30150_dirs_2022-01-07_0b3747d7-79cb-43c2-b7f6-ccd94c52e330.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-01-05
Reporting Person: Schaeffer Orlov S Nicole (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-05 | Common Stock | S | 1503 | $27.61 | Disposed | 50040 | Direct |
| 2022-01-06 | Common Stock | S | 1612 | $26 | Disposed | 48428 | Direct |
Footnotes
F1: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
F2: Includes 29 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
More from INSMED Inc
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19